Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.Financial_Report.xls
10-K - ANNUAL REPORT - Cannabics Pharmaceuticals Inc.amcm_10k31aug12.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R8.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R3.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R9.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R18.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R15.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R17.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R10.htm
EX-32.1 - CERTIFICATION - Cannabics Pharmaceuticals Inc.amcm_10k31aug12ex32.htm
EX-31.1 - CERTIFICATION - Cannabics Pharmaceuticals Inc.amcm_10k31aug12ex31.htm
v2.4.0.6
INCOME TAXES (Tables)
12 Months Ended
Aug. 31, 2012
Income Tax Disclosure [Abstract]  
Reconciliation of Income Taxes with Reported Taxes
    August 31, 2012   August 31, 2011
Net loss before income taxes $ 1,652 $ 107,310
         
Income tax recovery at statutory rates of 35%   578   37,500
Unrecognized benefits of non-capital losses   (578)   (37,500)
Total income tax recovery $ - $ -
Significant Components of the Deferred Tax Asset
    August 31, 2012   August 31, 2011
Deferred tax assets:        
Net operating loss carryforwards $ 144,000 $ 143,500
Valuation allowance   (144,000)   (143,500)
Net deferred tax asset $ - $ -